Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis

Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lung cancers

(2013) Xiaotian Wang et al.   FASEB JOURNAL

The Promyelocytic Leukemia Zinc Finger Protein: Two Decades of Molecular Oncology

(2012) Bandar Ali Suliman et al.   Frontiers in Oncology

Understanding PLZF

(2011) Marina Kolesnichenko et al.   CELL CYCLE

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

(2011) T. L. Lotan et al.   CLINICAL CANCER RESEARCH

Immunohistology—Past, Present, and Future

(2010) Trishe Y-M Leong et al.   ADVANCES IN ANATOMIC PATHOLOGY

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

(2010) A H M Reid et al.   BRITISH JOURNAL OF CANCER

T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells

(2010) Michael A Weinreich et al.   NATURE IMMUNOLOGY

The Impact of Tissue Fixatives on Morphology and Antibody-based Protein Profiling in Tissues and Cells

(2009) Linda Paavilainen et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

(2009) Bo Han et al.   MODERN PATHOLOGY

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

(2009) Brett S Carver et al.   NATURE GENETICS

The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival

(2009) M Cheung et al.   ONCOGENE

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

(2008) P McCall et al.   BRITISH JOURNAL OF CANCER

Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients

(2008) Georg Brunner et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms

(2008) F. Felicetti et al.   CANCER RESEARCH

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

(2008) Olaf Bettendorf et al.   GENES CHROMOSOMES & CANCER